Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)
Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –
Innoviva pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Innoviva's pe ratio was 4.6× on Nov 11, 2026, against 29.2× a year earlier. Over the last 5 years it ranged from 3.5× to 29.2×, with a median of 6.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.6× | −24.1 |
| 2025 | Jan 31, 2025 | 28.7× | +2.0 |
| 2024 | Dec 31, 2024 | 26.7× | +4.1 |
| 2023 | Dec 29, 2023 | 22.6× | +18.4 |
| 2022 | Dec 30, 2022 | 4.2× | −1.4 |
| 2021 | Dec 31, 2021 | 5.5× | −0.8 |
| 2020 | Dec 31, 2020 | 6.3× | +2.1 |
| 2019 | Dec 31, 2019 | 4.2× | −6.1 |
| 2018 | Dec 31, 2018 | 10.3× | −5.8 |
| 2017 | Dec 29, 2017 | 16.1× | −15.3 |
| 2016 | Dec 30, 2016 | 31.5× | – |
See a number that looks wrong?